Literature DB >> 2428791

Chemical modulation of bleomycin induced toxicity.

K A Kennedy, W N Hait, J S Lazo.   

Abstract

Both lidocaine (LIDO) and the calmodulin (CaM) antagonists, pimozide (PIM) and trifluoperazine (TFP), enhanced bleomycin (BLM) induced cytotoxicity and DNA damage. The toxicity with the combination of BLM and CaM antagonists represented true pharmacological synergism and was observed with the addition of the CaM antagonist either during or after BLM exposure. Additionally, the DNA damage of BLM and the BLM-like drugs, talisomycin S10b (TAL) or peplomycin (PEPLO), was also enhanced by CaM antagonists. LIDO, which similarly increased the lethal effects and DNA damage of BLM in L1210 cells, was also effective only during or after BLM exposure. The data presented here indicate that the modulation of toxicity seen with these drug combinations is reflected by changes in DNA integrity. Furthermore, these data suggest that the inhibition of DNA repair processes may be at least partially responsible for the enhanced toxicity and DNA damage when CaM antagonists or LIDO are added to BLM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428791     DOI: 10.1016/0360-3016(86)90173-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine.

Authors:  W N Hait; S Morris; J S Lazo; R J Figlin; H J Durivage; K White; P E Schwartz
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Anesthesia Medications and Interaction with Chemotherapeutic Agents.

Authors:  Jeremy Watson; Michael K Ninh; Scott Ashford; Elyse M Cornett; Alan David Kaye; Ivan Urits; Omar Viswanath
Journal:  Oncol Ther       Date:  2021-04-16

Review 3.  Potentiation of DNA damage and cytotoxicity by calmodulin antagonists.

Authors:  S A Rosenthal; W N Hait
Journal:  Yale J Biol Med       Date:  1988 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.